SIMULPHARMA ApS: Financial statements 2022
CVR: 32832075
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
SIMULPHARMA ApS (CVR 32832075) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 484,388 and a net result of DKK -58,155 compared with DKK -83,269 the year before. That is a decrease of 23.8% compared with the year before. The profit margin was -12%. Equity in the 2022 report amounted to DKK 79,818. The solvency ratio was 88.2%. The company had 1 employee in the financial year.
- Revenue
- DKK 484,388
- Gross Profit
- DKK 406,469
- Profit/Loss
- DKK -58,155
- Equity
- DKK 79,818
- Total Assets
- DKK 90,450
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 484K | 406K | -58K | 80K | 1 |
| 2021 | 636K | 636K | -83K | 138K | 1 |
| 2020 | 719K | 719K | 36K | 221K | 1 |
| 2019 | 905K | -15K | -13K | 185K | 1 |
| 2018 | 958K | 955K | 30K | 198K | 1 |
Official annual report
Keep an eye on SIMULPHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
SIMULPHARMA ApS has published its annual report for 2021. Revenue came to DKK 635,995, and the net result was DKK -83,269.
About SIMULPHARMA ApS
SIMULPHARMA ApS was a Danish company of the type Anpartsselskab based in Birkerød, founded in 2010. The company has been dissolved on 24 August 2026. The company was registered under the industry Engroshandel med andre maskiner og andet udstyr. The company has 1 employee (2025). In 2024, the company reported revenue of DKK 158,958 and a net result of DKK 41,292 compared with DKK -57,341 the year before. Equity in the 2024 report amounted to DKK 63,769.